Amphenol & Raymond James: Giants with Upside

In a market filled with slow-growing giants, two stand out: Amphenol and Raymond James. Amphenol, with a market cap of $184.6 billion, has shown impressive revenue growth of 35.6% over two years, with earnings per share up 49% and strong free cash flow margins. Raymond James, at $30.24 billion, has beaten its sector with 11.6% five-year revenue growth, 16.2% earnings gains from buybacks, and a top return on equity. In contrast, Baker Hughes, with a market cap of $63.96 billion, has shown weak fundamentals, lagging growth, and a high cost structure, making it less attractive for big gains. Invest in Amphenol at $155.86 or Raymond James at $155.09 for their forward price-to-earnings of 33.6 and 12.3, respectively. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/025eb8622a0251d2